Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001707788 | SCV000721570 | likely benign | not provided | 2020-01-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001222363 | SCV001394460 | likely benign | Familial hyperkalemic periodic paralysis | 2024-10-15 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001707788 | SCV003818748 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004530787 | SCV004118355 | uncertain significance | SCN4A-related disorder | 2023-05-24 | criteria provided, single submitter | clinical testing | The SCN4A c.2861C>T variant is predicted to result in the amino acid substitution p.Pro954Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.056% of alleles in individuals of South Asian descent in gnomAD, indicating it may be too common to be causative for an autosomal dominant disorder (http://gnomad.broadinstitute.org/variant/17-62026881-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Ambry Genetics | RCV004669056 | SCV005157673 | likely benign | Inborn genetic diseases | 2024-05-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |